Logo image of HZNP

HORIZON THERAPEUTICS PLC (HZNP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HZNP - IE00BQPVQZ61 - Common Stock

116.3 USD
+0.05 (+0.04%)
Last: 10/5/2023, 8:25:26 PM
116.34 USD
+0.04 (+0.03%)
After Hours: 10/5/2023, 8:25:26 PM
Fundamental Rating

6

Taking everything into account, HZNP scores 6 out of 10 in our fundamental rating. HZNP was compared to 525 industry peers in the Biotechnology industry. HZNP has an excellent financial health rating, but there are some minor concerns on its profitability. HZNP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year HZNP was profitable.
  • HZNP had a positive operating cash flow in the past year.
HZNP Yearly Net Income VS EBIT VS OCF VS FCFHZNP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 500M 1B

1.2 Ratios

  • HZNP's Return On Assets of 4.71% is amongst the best of the industry. HZNP outperforms 95.21% of its industry peers.
  • HZNP's Return On Equity of 8.25% is amongst the best of the industry. HZNP outperforms 95.38% of its industry peers.
  • HZNP's Return On Invested Capital of 5.35% is amongst the best of the industry. HZNP outperforms 95.87% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HZNP is significantly below the industry average of 18.07%.
Industry RankSector Rank
ROA 4.71%
ROE 8.25%
ROIC 5.35%
ROA(3y)6.1%
ROA(5y)6.05%
ROE(3y)10.47%
ROE(5y)10.88%
ROIC(3y)6.68%
ROIC(5y)4.8%
HZNP Yearly ROA, ROE, ROICHZNP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 20 -20

1.3 Margins

  • HZNP has a better Profit Margin (12.02%) than 96.04% of its industry peers.
  • In the last couple of years the Profit Margin of HZNP has declined.
  • HZNP has a better Operating Margin (15.58%) than 96.53% of its industry peers.
  • HZNP's Operating Margin has improved in the last couple of years.
  • HZNP has a Gross Margin of 75.21%. This is amongst the best in the industry. HZNP outperforms 84.49% of its industry peers.
  • In the last couple of years the Gross Margin of HZNP has grown nicely.
Industry RankSector Rank
OM 15.58%
PM (TTM) 12.02%
GM 75.21%
OM growth 3Y23.86%
OM growth 5YN/A
PM growth 3Y-31.18%
PM growth 5YN/A
GM growth 3Y1.14%
GM growth 5Y6.97%
HZNP Yearly Profit, Operating, Gross MarginsHZNP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 60

7

2. Health

2.1 Basic Checks

  • HZNP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, HZNP has about the same amount of shares outstanding.
  • HZNP has a better debt/assets ratio than last year.
HZNP Yearly Shares OutstandingHZNP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
HZNP Yearly Total Debt VS Total AssetsHZNP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 5.10 indicates that HZNP is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.10, HZNP belongs to the best of the industry, outperforming 81.35% of the companies in the same industry.
  • The Debt to FCF ratio of HZNP is 2.67, which is a good value as it means it would take HZNP, 2.67 years of fcf income to pay off all of its debts.
  • HZNP has a better Debt to FCF ratio (2.67) than 95.54% of its industry peers.
  • HZNP has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.48, HZNP is doing worse than 74.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 2.67
Altman-Z 5.1
ROIC/WACC0.75
WACC7.16%
HZNP Yearly LT Debt VS Equity VS FCFHZNP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 4.27 indicates that HZNP has no problem at all paying its short term obligations.
  • With a Current ratio value of 4.27, HZNP perfoms like the industry average, outperforming 41.58% of the companies in the same industry.
  • A Quick Ratio of 4.09 indicates that HZNP has no problem at all paying its short term obligations.
  • HZNP has a Quick ratio of 4.09. This is comparable to the rest of the industry: HZNP outperforms 40.92% of its industry peers.
Industry RankSector Rank
Current Ratio 4.27
Quick Ratio 4.09
HZNP Yearly Current Assets VS Current LiabilitesHZNP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

6

3. Growth

3.1 Past

  • The earnings per share for HZNP have decreased strongly by -19.39% in the last year.
  • Measured over the past years, HZNP shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.01% on average per year.
  • Looking at the last year, HZNP shows a decrease in Revenue. The Revenue has decreased by -4.42% in the last year.
  • Measured over the past years, HZNP shows a very strong growth in Revenue. The Revenue has been growing by 28.00% on average per year.
EPS 1Y (TTM)-19.39%
EPS 3Y34.76%
EPS 5Y33.01%
EPS Q2Q%12.15%
Revenue 1Y (TTM)-4.42%
Revenue growth 3Y40.8%
Revenue growth 5Y28%
Sales Q2Q%7.82%

3.2 Future

  • HZNP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.92% yearly.
  • Based on estimates for the next years, HZNP will show a quite strong growth in Revenue. The Revenue will grow by 9.94% on average per year.
EPS Next Y-5.01%
EPS Next 2Y8.89%
EPS Next 3Y11.9%
EPS Next 5Y15.92%
Revenue Next Year5.55%
Revenue Next 2Y9.53%
Revenue Next 3Y10.34%
Revenue Next 5Y9.94%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HZNP Yearly Revenue VS EstimatesHZNP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
HZNP Yearly EPS VS EstimatesHZNP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 25.90, the valuation of HZNP can be described as expensive.
  • Based on the Price/Earnings ratio, HZNP is valued cheaper than 95.54% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.21, HZNP is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 20.14, the valuation of HZNP can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, HZNP is valued cheaply inside the industry as 96.53% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 25.98. HZNP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 25.9
Fwd PE 20.14
HZNP Price Earnings VS Forward Price EarningsHZNP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HZNP is valued cheaply inside the industry as 94.88% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, HZNP is valued cheaper than 96.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.79
EV/EBITDA 27.94
HZNP Per share dataHZNP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The decent profitability rating of HZNP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.78
EPS Next 2Y8.89%
EPS Next 3Y11.9%

0

5. Dividend

5.1 Amount

  • HZNP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HORIZON THERAPEUTICS PLC / HZNP FAQ

What is the fundamental rating for HZNP stock?

ChartMill assigns a fundamental rating of 6 / 10 to HZNP.


What is the valuation status for HZNP stock?

ChartMill assigns a valuation rating of 5 / 10 to HORIZON THERAPEUTICS PLC (HZNP). This can be considered as Fairly Valued.


How profitable is HORIZON THERAPEUTICS PLC (HZNP) stock?

HORIZON THERAPEUTICS PLC (HZNP) has a profitability rating of 8 / 10.


What are the PE and PB ratios of HORIZON THERAPEUTICS PLC (HZNP) stock?

The Price/Earnings (PE) ratio for HORIZON THERAPEUTICS PLC (HZNP) is 25.9 and the Price/Book (PB) ratio is 5.01.